Assessment of Bioequivalence of Weak Base Formulations Under Various Dosing Conditions Using Physiologically Based Pharmacokinetic Simulations in Virtual Populations. Case Examples: Ketoconazole and Posaconazole.
Cristofoletti R, Patel N, Dressman JB. · Journal of pharmaceutical sciences · 2017 · Article
10.1016/j.xphs.2016.10.008
Verified evidence
Model scenario comparison
c6824499-5696-5d4d-91ee-cadce38c686dPrediction source Publisher proof · PDF page(s) 6
Study 314ee01c-e0d3-5aee-85a5-5ec902c51298 · Prediction record (JSON)
Prediction fields
- Endpoint
- peak_concentration · PDF page(s) 6
- Family
- pharmacokinetic_exposure · PDF page(s) 6
- Measured variable
- peak_concentration · PDF page(s) 6
- Metric
- peak · PDF page(s) 6
- Model
- mechanistic_or_numerical · PDF page(s) 1
- Population
- simulated_system · PDF page(s) 1, 6